OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Pat Garcia-Gonzalez at LeukO 2026: The CML Breakthrough That Still Hasn't Reached Everyone

FURTHER: Firmonertinib Shows Promising Activity in EGFR PACC-Mutant Advanced NSCLC

Sanam Loghavi: Aplastic Anemia vs Hypocellular MDS, Solving Dameshek’s Riddle

Patrick Soon-Shiong: New Publication Highlights Durable Responses in Non-Muscle-Invasive Bladder Cancer

Jay Bhattacharya: NIH FY2026 Shows Strong Investment in Research

Oncology News, Insights, Stories by OncoDaily

Sarcoma
OncoDaily Pulse

OncoDaily Grand Rounds at ESMO 2026: Partners Unite for Sarcoma Research

HELEN-Trio 011
Breast Oncology

HELEN-Trio 011: Camrelizumab Improves pCR With Anthracycline-Free Neoadjuvant Therapy in Stage II–III TNBC

Rachna Shroff
Hall of Fame

Remembering Rachna Shroff: The Sunshine She Leaves Behind

Can Live Tumor Biopsies Predict Immunotherapy Response?

At What Stage of Cancer Is Chemotherapy Used? A Stage-by-Stage Guide

Enrique Grande: Rethinking Research Priorities Across Prostate, Kidney and Bladder Cancer

Parker Institute Investigators’ Startups Azalea and Medici Named to 2026 Endpoints 11

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer

Regeneron’s Cemiplimab Receives CHMP Backing for Six-Weekly Dosing Across EU Indications

Lacy Hubbard: Breast Cancer Awareness Alone Cannot Save Lives if Care Remains Out of Reach

Voices
JAMA

How AI Is Changing Medical Evidence Review and Clinical Decision-Making - JAMA

Professor The Hon Greg Hunt Joins the International Advisory Board of Dr. Gevorg Tamamyan’s WHO Director-General Campaign

Stephen Liu: Multidisciplinary Discussion of Stage III NSCLC at AILCC26

Kirill Kirgizov: SIOP Welcomes New Scientific Committee Chair for Asia

Mark Lawler: Ireland Introduces Five-Year Right to Be Forgotten Period for Cancer Survivors

Mina Sedrak: The Best Medicine Is the Medicine You Can Take

Zeynep Birsu Çinçin: From Awareness to Adaptive Oncology - AI, Molecular Resistance, and Adaptive Oncology in Breast Cancer

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

OPN Southwest Chapter Conference 2026

Oncology Pharmacy Network

17 Oct
OPN Southwest Chapter Conference

19th AACR Conference on The Science of Cancer Health Disparities

American Association for Cancer Research

18 Oct
Cancer Health Disparities

Cytokines 2026: 14th Annual Meeting of The Cytokine Society

The Cytokine Society

18 Oct
Cytokines 2026

ESTRO - Evidence Based Radiation Oncology

European Society for Radiotherapy and Oncology (ESTRO)

19 Oct
Radiation Oncology

Rhabdomyosarcoma 2026: Advancing Science, Improving Outcomes

Memorial Sloan Kettering Cancer Center (MSK)

19 Oct
Rhabdomyosarcoma

VIDAWASI International Medical Congress 2026

VIDAWASI PERÚ

20 Oct
VIDAWASI

Association of Cancer Care Centers (ACCC) 43rd National Oncology Conference

Association of Cancer Care Centers

21 Oct
Association of Cancer Care Centers

Kidney Week 2026

American Society of Nephrology (ASN)

21 Oct
Kidney Week 2026

The Best of IMS Europe Webinar

International Myeloma Society (IMS)

21 Oct
IMS Asia Pacific Webinar

ESSO - Advanced Course on Breast Cancer Surgery

22 Oct
Breast Cancer Surgery

ESSO - Advanced Course on Pancreatic Cancer Surgery

European Society of Surgical Oncology

22 Oct
Pancreatic Cancer Surgery

Immune-oncology
Can Live Tumor Biopsies Predict Immunotherapy Response?

Can Live Tumor Biopsies Predict Immunotherapy Response?

KEYNOTE-966: Does Pembrolizumab Make Responses More Durable in Biliary Tract Cancer?

Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC

DECIDE-MET Trial: Targeted Therapy or Immunotherapy First in METex14 NSCLC?

KEYNOTE-B49 at ESMO 2026: Can Immunotherapy Find a Role in HR+/HER2− Breast Cancer?

INMC Analysis: Can Pathological Response Guide Treatment in Melanoma?

Gastrointestinal-Oncology
Daraxonrasib

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer

5 Pancreatic Cancer Trials to Watch at ESMO 2026

FFCD-AC: 1L Chemotherapy for Metastatic Recurrence of Ampullary Adenocarcinoma

Phase 3b SIERRA: Durvalumab Plus Tremelimumab in Poor-Prognosis Unresectable HCC

Phase 1b/2 HERBOT Trial: First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer

10 Must-Read Posts In GI Oncology This Week

9 Hepatobiliary Cancer Trials to Watch at ESMO 2026

Breast-Oncology
HELEN-Trio 011

HELEN-Trio 011: Camrelizumab Improves pCR With Anthracycline-Free Neoadjuvant Therapy in Stage II–III TNBC

ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes

MAMMÔ 2026: Precision, De-Escalation and New Treatment Sequencing Reshape Breast Cancer Care

Can Maintenance HER2 Therapy Be Stopped? Global Survey Reveals Clinical Equipoise in Long-Term Responders

NRG-BR002: Metastasis-Directed Ablation Fails to Improve PFS or OS in Oligometastatic Breast Cancer

Risk-Adapted Approach to Neoadjuvant Therapy in HER2-Positive Early Breast Cancer

How Systemic Therapy Is Reshaping Breast Cancer Care in 2026

Lung-Oncology
FURTHER

FURTHER: Firmonertinib Shows Promising Activity in EGFR PACC-Mutant Advanced NSCLC

LIGHT-NING: Real-World Nivolumab Plus Ipilimumab Shows Durable Outcomes in Metastatic NSCLC

Jazz EMERGE 402: Real-World Lurbinectedin Shows Clinically Meaningful Activity in Previously Treated SCLC

AENEAS2: Aumolertinib Plus Chemotherapy Extends PFS in EGFR-Mutant Advanced NSCLC

Unresectable Stage III NSCLC: PACIFIC Remains the Backbone as Precision Strategies Reshape Care

Hong Kong Model Finds EGFR/ALK-First Testing More Cost-Efficient Than Upfront NGS in Metastatic NSCLC

Small-Molecule Inhibitors in NSCLC: A 2026 Practical Guide to Drug Interactions and Toxicity

OncoDaily TV
Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

ONCOFFEE

ONCOFFEE: Cancer Care in Nepal, Global Oncology, and Bridging Resource Gaps with Vivek Ghosh

The CML Evolution

The CML Evolution: Mastering Modern Algorithms in Chronic Myeloid Leukemia

Not To Miss
Parker Institute

Parker Institute Investigators’ Startups Azalea and Medici Named to 2026 Endpoints 11

Breast Health Day 2026: Why Early Detection Matters and Why Screening Cannot Wait

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy

Merck at ESMO 2026: Phase 3 mRNA, TROP2 ADC and Pembrolizumab Data Lead 90+ Abstracts

RYZ101 Improves PFS in Phase 3 ACTION-1 Trial for GEP-NETs After Lutetium-177 Therapy

15 Posts Not To Miss From DCLung26

Over 30,000 People Join Breast Care International Walk for Greater Rural Breast Cancer Awareness in Ghana

OncoGrants
Cancer Health Research

American Cancer Society Cancer Health Research Centers (CHERCs) 2026

Postdoctoral Research

Charles A. King Trust Postdoctoral Research Fellowship 2027

Graduate Hematology Award

ASH Graduate Hematology Award 2027

Chordoma Foundation

CRI–Chordoma Foundation Impact Grant 2027

Solid Tumors

Gilead Sciences Research Scholars Program in Solid Tumors – US 2026

CRI IGNITE Award

CRI IGNITE Award 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Willem Lybaert

Willem Lybaert

Oncologists Location Sint-Niklaas, Belgium
Abeid Athman Omar

Abeid Athman Omar

Oncologists Location Nairobi, Kenya
Roberto Carmagnani Pestana

Roberto Carmagnani Pestana

Oncologists Location São Paulo, Brazil
Nicholas DeVito

Nicholas DeVito

Oncologists Location Durham, USA
Fan Daiming

Fan Daiming

Oncologists Location Xi'an, China
Jan Fagerberg

Jan Fagerberg

Oncologists Location Paris, France
Dinesh Pendharkar

Dinesh Pendharkar

Oncologists Location Faridabad, India
Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu

Oncologists Location Abuja, Nigeria

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Wafik S. El-Deiry

Wafik El-Deiry: Unraveling Cancer Plasticity and Histological Transformation in Precision Oncology

Lucia Santorelli

Lucia Santorelli: Landmark Study Uncovers Placental-Like Reprogramming in Early-Onset Colorectal Cancer

Sia Daneshmand

Sia Daneshmand: Combining Treatments to Improve Durable Responses in Non-Muscle-Invasive Bladder Cancer

Morgan Levy

Morgan Levy: Loved Sharing Hormone Therapy Work at ASCOQLTY26!

Kefah Mokbel

Kefah Mokbel: Your Genes Are Not Your Destiny - Lifestyle Matters in Breast Cancer Prevention!

Premal Patel

Premal Patel: Beyond Biomarkers, Elephas Platform Predicts Immunotherapy Response Using Live Patient Tumor Tissue

OncoDaily Medical Journal

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts